Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5907_Библиотеки_им_академика_М_И_Перельмана.pdf
X
- •Preface
- •1.1: Polymer Chains Behavior in Solutions
- •1.1.1: Basic Interaction of Polymer Chain in Solution
- •1.2.1: Self-Assembly of Block Copolymers
- •1.2.2: Self-Assembly of Liposomes
- •1.2.2.1: Formation of liposomes
- •1.1.2: Solubility of Polymer
- •1.1.2.1: Solubility parameter
- •1.1.2.2: Real polymer solutions
- •1.1.3.1: Dynamics of self-assembly
- •1.1.3.2: Free energy of self-assembly systems
- •1.1.3.3: Basic morphology of self-assembly systems
- •1.2.2.2: Phase behaviors of lipid bilayers
- •1.3: Stability of Nanosystems in Solutions
- •1.3.1: DLVO Theory
- •1.3.1.1: Interaction energy between nanoparticles
- •1.3.1.2: Effects of DLVO theory
- •1.3.3: Limitations of Classical DLVO
- •1.4: The Powerful Tool for Study of Nano Physical Pharmaceutics
- •1.4.1.1: Scattering by a small particle
- •1.4.2.1: Power spectrum of scattered light
- •2.1: Classification of Micelle
- •2.1.1: Ionic Surfactant Micelle
- •2.1.2: Non-Ionic Surfactant Micelle
- •2.1.3: Mixed Micelle
- •2.2: Preparation of Micelles
- •2.3: Effects on Micelle Assembly
- •2.3.1: Critical Micelle Concentration
- •2.3.2: Mechanism of Micellization
- •2.3.3: Influence of the Surfactant Structure on CMC
- •2.3.3.1: Volume of hydrophobic groups
- •2.3.3.2: Chemical structure and volume of hydrophilic groups
- •2.3.4: Influence of External Conditions on CMC
- •2.3.4.1: Temperature
- •2.3.4.2: Electrolytes
- •2.3.4.3: Organic substances
- •2.4: Structure and Stability of Polymeric Micelles
- •2.4.1: Thermodynamical Stability
- •2.4.2: Structural Stability
- •2.4.3: Micelle Structural Tailoring
- •2.5: NPP of Polymeric Micelles in Drug Delivery
- •2.5.1: Physiochemical Properties of Micelles
- •2.5.1.2: Critical micelle concentration
- •2.5.1.3: Zeta potential
- •2.5.2: Stability of Micelles
- •2.5.3: Drug-Loading Profile of Micelles
- •2.5.4: Endocytosis of Micelles
- •2.5.5: Drug Release Behavior of Micelles
- •2.5.6.1: pH-responsive micelles
- •2.5.6.2: Redox-responsive micelles
- •2.5.6.3: Temperature-responsive micelles
- •2.5.6.4: Photo-responsive micelles
- •2.6: Summary and Perspective
- •3.1: Classification of Liposome
- •3.2: Preparation of Liposomes
- •3.2.2: Reverse-Phase Evaporation Method
- •3.2.3: Injection Method
- •3.2.4: Detergent Depletion Method
- •3.3: Theory of Liposome Formation
- •3.4: NPP of Liposomes in Drug Delivery
- •3.4.1: Physiochemical Properties of Liposome
- •3.4.1.1: Size of liposome
- •3.4.1.2: Phase transition temperature of liposome
- •3.4.1.3: Membrane permeability of liposome
- •3.4.1.4: Membrane charge of liposome
- •3.4.2: Drug-Loading Behavior of Liposome
- •3.4.3: Stability of Drug-Loaded Liposome
- •3.4.3.1: Physical stability of drug-loaded liposome
- •3.4.3.2: Chemical stability of drug-loaded liposome
- •3.4.4: Clearance and in vivo Circulation of Liposome
- •3.4.5: Targeting Ability of Liposome
- •3.4.6: Drug Release Behavior of Liposome
- •3.5: Summary and Perspective
- •4.1: Classification of Inorganic Nanoparticles
- •4.3.1: Nucleation Mechanism of Inorganic Nanoparticles
- •4.3.2: Growth Mechanism of Inorganic Nanoparticles
- •4.3.3: Morphology Control Strategy
- •4.3.3.1: Control of nucleation rate
- •4.3.3.2: Control of growth phases
- •4.3.4: Dynamic Stability
- •4.3.4.1: Brownian motion
- •4.3.4.2: Sedimentation and sedimentation equilibrium
- •4.3.4.3: Interparticle interactions
- •4.3.5: Thermodynamic Stability
- •4.3.5.1: Electrical double layer theory and zeta potential
- •4.3.5.2: Electrolyte
- •4.3.5.3: DLVO theory
- •4.3.5.4: Stability in aqueous system
- •4.3.5.5: Impact of polymer compounds on stability
- •4.4: NPP of Inorganic Particles
- •4.4.1: Properties of Inorganic Nanoparticles
- •4.4.1.1: Electronic and optical properties
- •4.4.1.2: Magnetism
- •4.4.1.3: Mechanical properties
- •4.4.1.4: Thermal properties
- •4.4.2: Biological Application of Inorganic Nanoparticles
- •4.4.2.1: Au nanoparticles
- •4.4.2.2: Magnetic nanoparticles
- •4.4.2.3: Quantum dots
- •4.4.2.4: Carbon nanotubes
- •4.4.2.5: MXene
- •4.5: Summary and Perspective
- •5.1: Classification of Nanogels
- •5.2: Preparation of Nanogels
- •5.2.1: Non-Covalent Bonding Method
- •5.2.2: Chemical Cross-Linking Reaction
- •5.2.3: Template Method
- •5.3: Mechanism of Nanogel Formation
- •5.3.1: Cross-Linking of Nanogel
- •5.3.1.1: Gelation theory of nonlinear polycondensation
- •5.3.3: Structure and Stability of Nanogel
- •5.4: NPP of Nanogels in Drug Delivery
- •5.4.1: Physiochemical Properties of Nanogels
- •5.4.1.1: Expansion of nanogels
- •5.4.1.2: Swelling mechanism
- •5.4.1.3: Affecting factors of nanogel swelling
- •5.4.1.4: Thixotropy and desizing effect of nanogels
- •5.4.2: In vivo Circulation of Nanogels
- •5.4.3: Drug Release Behavior of Nanogels
- •5.4.4: Factors Affecting the Release of Drug-Loaded Nanogels
- •5.4.4.1: Drug-loading methods
- •5.4.4.2: Medium pH
- •5.4.4.3: Solvent
- •5.4.4.4: Particle size
- •5.4.4.5: Surface charge
- •5.4.5.1: Temperature-responsive nanogels
- •5.4.5.2: pH-responsive nanogels
- •5.4.5.3: Glucose-responsive nanogels
- •5.4.5.4: Photoresponsive nanogels
- •5.4.5.5: Other stimulation-responsive nanogels
- •5.4.6.1: Delivery of small-molecule therapeutic drugs
- •5.4.6.2: Delivery of oligonucleotides
- •5.4.6.3: Delivery of therapeutic proteins
- •5.5: Summary and Perspective
- •6.1: Classification of Microspheres
- •6.2: Preparation of Microspheres
- •6.2.1: Emulsification: Chemical Cross-Linking Method
- •6.2.2: Solvent Evaporation
- •6.2.3: Phase Separation
- •6.2.4: Salting-Out Method
- •6.2.5: Spray Drying
- •6.2.6: Ultrasound Method
- •6.2.7: Supercritical Fluid Method
- •6.3: Mechanism of Microsphere Formation
- •6.3.1: Stability of Nano-Microspheres and DLVO Theory
- •6.3.2: Factors Affect the Potential Energy
- •6.3.3: Factors Affect the Stability of Microspheres
- •6.3.3.1: Properties of polymers
- •6.3.3.2: Surface charge of microspheres
- •6.4: NPP of Microspheres
- •6.4.1: Physicochemical Properties of Microspheres
- •6.4.1.2: Factors affecting the particle size of microspheres
- •6.4.3: Drug Release Behavior of Microspheres
- •6.4.3.1: Mechanism of drug release by microspheres
- •6.4.3.2: PLA microspheres delivery system
- •6.4.4: Route of Administration of Microspheres
- •6.4.4.1: Cavity administration
- •6.4.4.2: Injection administration
- •6.4.4.3: Administration by arterial embolism
- •6.4.4.4: Magnetic microsphere administration
- •6.4.4.5: Oral administration
- •6.4.4.6: Mucosal administration
- •6.4.4.7: Ocular administration
- •6.4.5: Biological Application of Microspheres
- •6.4.5.1: Sustained-release microsphere formulation
- •6.5: Summary and Perspective
- •Index

84
Nano Physical Pharmaceutics of Micelle-Based Systems
copolymers. Cui et al. have synthesized a high-molecular polymer
mPEG-S-S-C16 with redox properties and used it to load the
chemotherapy drug DOX. In vitro experiments show that under
disintegrated, and the wrapped DOX can be quickly released, and
2.5.6.3 Temperature-responsive micelles
Temperature is one of the most common sources of stimulation.
Temperature-responsive polymeric micelles are assembled from
copolymers with temperature-responsive blocks, where the
aqueous properties of such copolymers change drastically at a
certain temperature and the corresponding micelles release the
drug through phase inversion. The temperature at which
the transition occurs is referred to as lower critical solution
temperature (LCST) or upper critical solution temperature (UCST)
of the polymer. When the temperature is below LCST or above
UCST, hydrogen bonds are formed between polymer and water and
dissolve. When the temperature is above LCST or below UCST, the
hydrogen bonds between water and polymer chains are broken
and polymer precipitates. Currently, the most widely used
temperature-responsive polymer is PNIPAAm when LCST is
around 32 °C. In addition, Pluronics and P(HPMAm-Lacn) are
thermo-responsive poly(N-isopropylacrylamide-b-lauryl acrylate)
(PNIPAAm-b-PLA) with tailored molecular weight through
reversible addition-fragmentation chain-transfer (RAFT)
polymerization to prepare drug-loaded smart micelle. The micelle
experienced phase transition when the temperature rise up above
the LCST and showed a sustained drug release rate [54].
2.5.6.4 Photo-responsive micelles
Photo-responsive micelles usually undergo structural
mainly through photo-induced transition of hydrophobicity–
hydrophilicity or photo-cleavage reaction [55, 56]. Photochromic
moieties such as coumarin, azobenzene, spiropyran, and 2-diazo-

Summary and Perspective
85
1,2-naphthoquinone are commonly introduced to construct
photo-responsive block polymers. For example, The conformation
of azobenzene groups and its derivatives changes from the
apolar trans form to the polar cis form upon light irradiation
(340–380 nm), then reforms to the orginal state after being
exposed to irradiation at 420–490 nm or put into the dark.
Compared with the cis-azo bond (dipole moment, μ = 3D), the
trans-azo bond has a smaller polarity (dipole moment, μ = 0D)
and stronger hydrophobicity, which may be utilized to control the
assembly and disruption of azo-containing polymeric micelles in
repeated cycles and facilitate drug release. Spiropyran is another
promising photoisomerization group which can exist in two
states, the hydrophilic zwitterionic merocyanine state and the
hydrophobic SP state. These two states can transform into each
other through a reversible isomerization either upon visible
light (620 nm) irradiation (from hydrophilic to hydrophobic) or
the UV (365 nm) irradiation (from hydrophobic to hydrophilic).
Block copolymer with spiropyran showed improved light
hydrophilic and hydrophobic state compared with azo moieties.
2.6 Summary and Perspective
Polymeric micelles have shown various advantages as nanocarriers
for drug delivery. They can realize the solubilization of waterinsoluble drugs through hydrophobic interactions, and achieve
enrichment in tumor tissues through enhanced permeability
in vitro and in
vivo environments, and the complex composition of our internal
environment (e.g., blood) encountered in practical applications,
there are multiple interactions between micelles and biological
macromolecules, which makes the precise and rational design
of micelles a great challenge. At the same time, the special
pathological conditions of tumor microenvironment have stricter
requirements on the targeting and nanomedicine. Only when our
understanding of disease physiology is matched by advances in

86
Nano Physical Pharmaceutics of Micelle-Based Systems
materials science, will it be possible to achieve larger breakthroughs
This chapter attempts to link the physical and chemical
parameters of micelles with interactions in vivo, for example, how
to regulate the particle size and zeta potential of the corresponding
the chemical structure of amphiphilic polymers. It aims to provide
theoretical basis and guidance for the precise design of micelles to
for tumors.
References
1. Torchilin VP, J Controll Release 2001, 73
Gupta
technologies,
80–118.
for the
for Poorly Water-Soluble Drugs
Solvents and Self-Organization
Tuzar Z, eds), Springer, Netherlands: Dordrecht, 1996, pp. 19–32.
9. Jean FG,
Interface Sci 2011
184–202.
A, Cardiovascular nanomedicine:
Nanomaterials
in
S,
Vaze OS, Movassaghian S, Torchilin
delivery
Anionic Polymerization
of poorly soluble
Adv. Colloid Interface Sci
J Phys Chem
J Colloid Interface Sci
and nonequilibrium
Proc Natl Acad Sci
J Pharm Sci 1976 65
, 162
Nanomedicine
1974 71
, , 1541–1544.
2021
16 Eur J Pharm Sci 2016, 83,
, Springer: Tokyo,
materials
in
Pharmacology
Adv Drug Deliv Rev 2020 156
drugs,
. 2014, 203
1951 55
of Polymers
,
Drug
in
, 51–54.
, , 644–655.
, , 634–641.
1968 27
Z-R, Sakuma
VP, Polymeric
Delivery
polymer in
2015
SE, Munk P,
and
S,
, ,
micelles
Strategies
micelles,
Adv Colloid

References
87
15. Gohy J-F, Block copolymer micelles, in (Abetz V,
ed), Springer, Berlin Heidelberg: Berlin, Heidelberg, 2005, pp. 65–
Block Copolymers II
136.
micelles
in
(Alexandridis
Br Polymer J
nonaqueous
P, Lindman
1984
16
solution,
B, eds), Elsevier
in Amphiphilic
Science
Block
Copolymers
B.V., Amsterdam,
2000, pp. 115–149.
P, Modelling
solvent,
in Amphiphilic
of the
self-assembly
Block
of block
Copolymers
copolymers
P,
in selective
Lindman
B,
eds), Elsevier Science B.V., Amsterdam, 2000, pp. 13–40.
19. Daoud M, Cotton JP, J Phys France
Macromolecules 1983
Macromolecules
Li W, Nakayama M, Akimoto J, Okano
, 43
J Chem Phys
, 531–538.
16
1983, 79
1996
29
T,
Polymer
20
, 8999–8999.
11
,
52,
24. Nagarajan R, ,
Li W, Li J, Gao
Biomaterials
Li W, Zhao H, Qian W, 32Li H, Zhang
Langmuir
J, Li B, , Xia
2011
2002
Y, Meng 18Y, Yu Y, Chen H, Dai J, Wang H, Guo Y,
, 3832–3844.
Biomaterials
L, Ye Z, Zhang
G, , Xia
2012
33, 5349–5362.
M, Li J, Gao J,
Int J Nanomedicine 2018 13
, ,
2921–2942.
Bioactive
Polymeric Systems 1985
531–585.
Macromolecules 1996,
29, ,
,
Coudane J, El Omar F, Nottelet B,
J Polym SciPart B: Polym Phys ,
, 924–934.
56
W, Zhao H, Qian W, Li H, Zhang
Adv Drug Deliv Rev
J Mater Chem B 2016 4
L, Ye Z, Zhang
Biomaterials
2012
64,
J Polym Res 2014,
G, , Xia
2012
33, 5349–5362.
, 6228–6239.
, 452.
21
2018
M, Li J, Gao J,

88
Nano Physical Pharmaceutics of Micelle-Based Systems
, ,
Macromolecules 1996
29
Drug Deliv Rev 2001,
Adv ,
47
113–131.
,
Adv Drug Deliv Rev
W, Masamichi
2010
J Pharm Sci
N, Jun A, Teruo
, 131–135.
63
2008
O,
Polymer 972011,
52
Doris E, , 5, 1955–1960.
Nanoscale
D, Zhou Y, Li X, Qu X,
ACS Appl Mater Interfaces
Cho C-S,
283
J Control Release
B, Fang
C, You MX, Zhang
2013
Deng
Y, Wang Z, He C, Zou Y, Jin Y, Liu Y,
2017
, 9, 6916–6930.
,
1998
Y, 51Fu S, Pei Y, ,
Colloid
Langmuir , 22,
Polym Sci 2005
2006
Toleikis
Biointerfaces 1999 16
,
P, Embree L, Hunter WL,
Chem Rev
Colloids Surf B:
2016, 116,
2602–2663.
Adv Colloid Interface Sci
Wang
2018
Z, Deng
, 535
X, Ding
, 253–260.
Fleige E, Quadir MA, Haag R,
51. Yang
YQ, Lin WJ, Zhao B, Wen XF,
28
, 8251–8259.
Wang C, Wang G, Wang Z, Zhang X,
2022,
307
J, Zhou
W, Zheng X, Tang G,
Polymer
Adv Drug Deliv Rev
Guo XD, Zhang
Int J Pharm
2009 50
2012
64
LJ,
Langmuir 2012
Chemistry – A Eur J 2011, 17,
3322–3325.
53.
Sarisozen C,
responsive
drug
delivery,
Drug
Delivery
Joshi U,
polymeric
in
Applications
Mendes
micelles
Stimuli
LP,
for
Responsive
Torchilin VP,
extracellular
Polymeric
ASH, Abu-Thabit
10
- Stimuli-
and
intracellular
Nanocarriers
for
NY, eds),
Woodhead Publishing, 2019, pp. 269–304.
,

References
89
54. Ghasemi S, Ahmadi L, Farjadian, F, , ,
J Mater Sci 2022 57
Soft Matter 2014, 10, 6121–6138.
56. Sana B, Finne-Wistrand A, Pappalardo D, Mater Today Chem 2022
25, 100963.
,


Chapter 3
Nano Physical Pharmaceutics of
Liposome-Based System
Nian Huang,
a
Mengxin Zhao,a Jian Wang,b and Wei Li
a
a
Department of Nanomedicine, Naval Medical University,
Shanghai 200433, China
National Advanced Medical Engineering Research Center,
Shanghai 201203, China
liwei_dds@163.com
3.1 Classification of Liposome
Nano Physical Pharmaceutics
Edited by Wei Li
Copyright © 2025 Jenny Stanford Publishing Pte. Ltd.
ISBN 978-981-4968-52-2 (Hardcover), 978-1-003-51393-3 (eBook)
www.jennystanford.com

92
Nano Physical Pharmaceutics of Liposome-Based System
Figure 3.1 Schemac diagram of the structures of liposomes with dierent
structures.
3.2 Preparation of Liposomes
3.2.1 Thin-Film Hydraon Method
I

Preparation of Liposomes
93
3.2.2 Reverse-Phase Evaporation Method
3.2.3 Injection Method
Соседние файлы в папке Библиотека им академика М.И. Перельмана
